Trial Profile
A phase I trial of CP-001 for the treatment of metabolic syndrome
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 17 Jan 2017
Price :
$35
*
At a glance
- Drugs CP 001 (Primary)
- Indications Metabolic syndrome; Type 2 diabetes mellitus
- Focus Adverse reactions; First in man
- 17 Jan 2017 New trial record